Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
| Autor: | Vansteenkiste, J. 1, *, Barlesi, F. 2, Waller, C.F. 3, Bennouna, J. 4, Gridelli, C. 5, Goekkurt, E. 6, Verhoeven, D. 7, Szczesna, A. 8, Feurer, M. 9, Milanowski, J. 10, Germonpre, P. 11, Lena, H. 12, Atanackovic, D. 13, Krzakowski, M. 14, Hicking, C. 15, Straub, J. 15, Picard, M. 15, Schuette, W. 16, O'Byrne, K. 17 |
|---|---|
| Zdroj: | In Annals of Oncology August 2015 26(8):1734-1740 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|